Avantor Inc (AVTR) Stock Price, Quote & News

Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610 386 1700

Website: www.avantorsciences.com

Address:

Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, United States

OptionRunners Oct. 27 at 3:04 PM

$AVTR Buyer of the November 21st $16 puts (ITM) 1,000 times for $1.68-$1.75 ahead of earnings on 10/29

0 · Reply

JarvisFlow Oct. 24 at 12:13 PM

Baird updates rating for Avantor ( $AVTR ) to Outperform, target set at 15 → 17.

0 · Reply

RunnerSignals Oct. 21 at 3:39 AM

$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look

0 · Reply

dudebob Oct. 17 at 7:23 PM

~50,000 $KODK for the pharma precursors play. Long & strong 💪 Thoughts $DJT $AVTR $JNJ $TEVA ? Is this a foolish move, or a decent long term play?

0 · Reply

ZacksResearch Oct. 17 at 4:53 PM

$AVTR partners with BlueWhale Bio — a promising step for CAR-T therapy? 🤔 Despite shares being down 30.8% YTD, this strategic move could enhance Avantor's role in cell therapy, leveraging its bioprocessing strength and BlueWhale's CDNP technology to streamline production and drive long-term growth. 📈 Discover the full potential here 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-body-16643&ADID=SYND_STOCKTWITS_TWEET_2_2771361_BODY_16643

0 · Reply

MoneyGroupLLC Oct. 17 at 4:17 PM

Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $1.10 - $1.80 Take Profit: $1.87 Stop Bleeding: $0.97 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

ZacksResearch Oct. 17 at 3:53 PM

$AVTR teaming up with BlueWhale Bio — a big move in the CAR-T space. 💥 The partnership uses CDNP tech to accelerate manufacturing, scale production, and widen patient access — strong strategic alignment. See what this means for Avantor’s growth path 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-teaser-16634&ADID=SYND_STOCKTWITS_TWEET_2_2771361_TEASER_16634

0 · Reply

SilverEagle Oct. 16 at 4:14 PM

$AVTR yeeeet

0 · Reply

JarvisFlow Oct. 16 at 4:10 PM

Raymond James updates rating for Avantor ( $AVTR ) to Outperform, target set at 14 → 16.

0 · Reply

SilverEagle Oct. 9 at 9:13 PM

$AVTR bottomed?

0 · Reply

Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables

Oct 15, 2025, 8:05 AM EDT - 12 days ago

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

Oct 13, 2025, 4:05 PM EDT - 13 days ago

Avantor® Announces Board Chairman Transition

Oct 3, 2025, 8:05 AM EDT - 24 days ago

Avantor® Appoints Gregory T. Lucier to its Board of Directors

Oct 1, 2025, 8:05 AM EDT - 26 days ago

Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025

Aug 16, 2025, 8:19 AM EDT - 2 months ago

Engine Capital takes a stake in Avantor. Activist sees several ways to create value

Aug 11, 2025, 9:33 AM EDT - 2 months ago

Avantor® Reiterates Shareholder Value Creation Focus

Aug 11, 2025, 8:46 AM EDT - 2 months ago

Activist investor Engine Capital urges Avantor to refresh board with new directors

Aug 11, 2025, 7:00 AM EDT - 2 months ago

Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value

Aug 10, 2025, 10:24 PM EDT - 2 months ago

Engine Capital builds stake in Avantor, plans to push it to sell itself, WSJ reports

Aug 10, 2025, 6:00 PM EDT - 2 months ago

Activist Investor to Push Avantor to Sell Itself

Aug 1, 2025, 2:35 PM EDT - 3 months ago

Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure

Aug 1, 2025, 10:42 AM EDT - 3 months ago

Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 6:05 AM EDT - 3 months ago

Avantor® Reports Second Quarter 2025 Results

Jul 21, 2025, 7:05 AM EDT - 3 months ago

Avantor Announces Emmanuel Ligner as Next President and CEO

Jun 27, 2025, 8:05 AM EDT - 4 months ago

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Jun 27, 2025, 12:55 AM EDT - 4 months ago

Avantor: Unloved Lab And Medical Testing Supplier Under Heavy Accumulation

May 16, 2025, 8:30 AM EDT - 5 months ago

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

May 2, 2025, 8:05 AM EDT - 6 months ago

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 9:28 AM EDT - 6 months ago

Avantor Analysts Cut Their Forecasts After Q1 Results

Apr 26, 2025, 5:01 AM EDT - 6 months ago

Avantor: A Healthier Diagnosis As Expectations Cool

Apr 25, 2025, 12:24 PM EDT - 6 months ago

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Apr 25, 2025, 11:11 AM EDT - 6 months ago

Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut

Apr 25, 2025, 10:53 AM EDT - 6 months ago

Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript

Apr 25, 2025, 6:07 AM EDT - 6 months ago

Avantor® Announces CEO Transition

Apr 25, 2025, 6:05 AM EDT - 6 months ago

Avantor® Reports First Quarter 2025 Results

Apr 1, 2025, 8:05 AM EDT - 7 months ago

Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX

Mar 28, 2025, 8:05 AM EDT - 7 months ago

Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025

Mar 17, 2025, 7:05 AM EDT - 8 months ago

Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

Feb 19, 2025, 8:05 AM EST - 8 months ago

Avantor® to Present at TD Cowen's 45th Annual Health Care Conference

Feb 19, 2025, 8:03 AM EST - 8 months ago

Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology

Feb 7, 2025, 11:08 AM EST - 9 months ago

Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript

Feb 7, 2025, 9:15 AM EST - 9 months ago

Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

Feb 7, 2025, 6:05 AM EST - 9 months ago

Avantor® Reports Fourth Quarter and Full Year 2024 Results

Feb 3, 2025, 6:00 AM EST - 9 months ago

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

MRVI

Jan 10, 2025, 8:05 AM EST - 10 months ago

Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025

Jan 3, 2025, 8:05 AM EST - 10 months ago

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 18, 2024, 4:15 AM EST - 11 months ago

Avantor: Durable FCF Generator Trading For Cheap

Nov 20, 2024, 8:05 AM EST - 1 year ago

Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 20, 2024, 7:30 AM EST - 1 year ago

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology

QSI

Nov 14, 2024, 8:05 AM EST - 1 year ago

Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges

Nov 6, 2024, 8:05 AM EST - 1 year ago

Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors

Oct 25, 2024, 2:52 PM EDT - 1 year ago

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 6:05 AM EDT - 1 year ago

Avantor® Reports Third Quarter 2024 Results

Oct 23, 2024, 8:05 AM EDT - 1 year ago

Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges

Oct 18, 2024, 7:35 AM EDT - 1 year ago

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

Oct 18, 2024, 7:05 AM EDT - 1 year ago

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Sep 30, 2024, 8:05 AM EDT - 1 year ago

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

Sep 27, 2024, 8:05 AM EDT - 1 year ago

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

Sep 25, 2024, 9:05 AM EDT - 1 year ago

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

OptionRunners Oct. 27 at 3:04 PM

$AVTR Buyer of the November 21st $16 puts (ITM) 1,000 times for $1.68-$1.75 ahead of earnings on 10/29

0 · Reply

JarvisFlow Oct. 24 at 12:13 PM

Baird updates rating for Avantor ( $AVTR ) to Outperform, target set at 15 → 17.

0 · Reply

RunnerSignals Oct. 21 at 3:39 AM

$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look

0 · Reply

dudebob Oct. 17 at 7:23 PM

~50,000 $KODK for the pharma precursors play. Long & strong 💪 Thoughts $DJT $AVTR $JNJ $TEVA ? Is this a foolish move, or a decent long term play?

0 · Reply

ZacksResearch Oct. 17 at 4:53 PM

0 · Reply

MoneyGroupLLC Oct. 17 at 4:17 PM

Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $1.10 - $1.80 Take Profit: $1.87 Stop Bleeding: $0.97 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

ZacksResearch Oct. 17 at 3:53 PM

0 · Reply

SilverEagle Oct. 16 at 4:14 PM

$AVTR yeeeet

0 · Reply

JarvisFlow Oct. 16 at 4:10 PM

Raymond James updates rating for Avantor ( $AVTR ) to Outperform, target set at 14 → 16.

0 · Reply

SilverEagle Oct. 9 at 9:13 PM

$AVTR bottomed?

0 · Reply

BEATOFtheMARKET Oct. 9 at 3:49 PM

Results for list 9/26/25 $AVT $AVTR $AVXL $AVY 🔥 Cycle Trading Signal plugged into AI 🔥

0 · Reply

T_L808 Oct. 8 at 1:58 PM

$AVTR daily chart this time, nice pattern under ytd vwap

0 · Reply

Winning_calls Oct. 6 at 1:27 AM

$AVTR pick me up @ $14.30

0 · Reply

MoneyGroupLLC Oct. 4 at 4:02 AM

Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $0.95 - $1.00 Take Profit: $1.61 Stop Bleeding: $0.84 ROI Potential: 70% Exit Within: 360 Minutes https://moneygroup.us/alerts

1 · Reply

T_L808 Oct. 3 at 3:43 PM

$AVTR watching @ $15.34

0 · Reply

JarvisFlow Oct. 2 at 2:04 PM

Barclays has updated their rating for Avantor ( $AVTR ) to Overweight with a price target of 15.

0 · Reply

healthcareguru Sep. 30 at 2:04 AM

Healthcare M&A Takeout / Must-Own Basket: $AXGN $AVTR $ADMA $EVH $SGRY 🔥💪👍💵

1 · Reply

SQUEAKSBANDIT Sep. 29 at 12:36 AM

$AVTR one word- oversold will be interesting to see how the activist investor scenario plays out

0 · Reply

MoneyGroupLLC Sep. 26 at 5:22 AM

Enter: $AVTR OCT 17 2025 $13 CALLS Buy in Price: $0.25 - $0.35 Take Profit: $0.57 Stop Bleeding: $0.22 ROI Potential: 130% Exit Within: 295 Minutes https://moneygroup.us/alerts

0 · Reply

DarthWallstreet Sep. 24 at 5:42 PM

$AVTR Add here if you like $!!

0 · Reply

DarthWallstreet Sep. 24 at 5:29 PM

$AVTR I’m betting this is the bottom. Then again my great grandfather bet the Titanic wouldn’t sink. Getting calls from my loan shark Freddy the Forehead, this better pop soon!!!

0 · Reply

healthcareguru Sep. 24 at 2:11 PM

$EVH getting ready to sell themselves to a strategic, clearly…deleveraging, FCF improving, guidance derisked. MUST OWN M&A Basket!! 🔥💪💵 $ADMA $AXGN $AVTR $SGRY

1 · Reply

Market Cap	10.50B
Revenue (ttm)	6.78B
Net Income (ttm)	711.50M
EPS (ttm)	N/A
PE Ratio	15.46
Forward PE	16.30
Profit Margin	10.49%
Debt to Equity Ratio	0.67

Volume	7,360,579
Avg Vol	10,478,856
Day's Range	N/A - N/A
Shares Out	681.74M
Stochastic %K	78%
Beta	0.98
Analysts	Sell
Price Target	$14.66